Illumina Ventures — Full Portfolio

Pattern develops rapid antibiotic susceptibility and infection diagnostics using single-cell microbiology, which reads the metabolic patterns of individual bacterial cells to deliver ID/AST results in hours without culture steps.

BiotechHealthtechMedical DevicesAustin, US

Nick Arab(Founder & CTO)Ross Johnson(Co-founder & Chief Engineer)Carey-Ann Burnham(Chief Executive Officer)Travis Davies(SVP, Operations)Kyle Fieleke(SVP, Corporate Development & Finance)David Bussian(SVP, Clinical, Regulatory & Assay Development)

Co-investorsAMR Action Fund

Pluton is developing a sun-powered, soil-surface biological nutrient system that uses photosynthetic microbial consortia to fix atmospheric nitrogen, improve phosphorus availability, and add carbon to soil for crop growers.

AgTechBiotechClimate TechSt. Louis, US

Barry Goldman(Co-founder)Elizabeth Gallegos(Chief Executive Officer)Jerry Steiner(Executive Chair)Charlie Walch(Executive Officer, Director)Glendon Schuster(Director)

Co-investorsFirst In VenturesRadicle GrowthBetter VenturesFall Line CapitalGrantham FoundationRA Capital+4 more

Precede Biosciences develops a blood-based diagnostic platform that profiles gene expression from cell-free DNA to reveal disease biology at the transcriptional level for drug developers and clinical trials.

AI & Machine LearningBiotechDigital HealthBoston, US

Rehan Verjee(Co-Founder, Chief Executive Officer, Board Director)Sylvan Baca(Co-Founder; Assistant Professor of Medicine, Dana-Farber Cancer Institute)Toni Choueiri(Co-Founder; Director, Lank Center for GU Oncology, Dana-Farber Cancer Institute)Matthew Freedman(Co-Founder; Professor of Medicine, Dana-Farber Cancer Institute)

Co-investors5AM VenturesOUP (Osage University Partners)Lilly Asia VenturesOsage University Partners

Predicta Biosciences operates a molecular insights platform for blood cancer care, using whole genome sequencing of intact circulating tumor cells from a single blood sample combined with single-cell immune profiling to characterize disease biology and immune response.

BiotechDigital HealthMedical DevicesCambridge, US

Irene Ghobrial(Co-founder)Kenneth Anderson(Co-founder)Gad Getz(Co-founder)Romanos Sklavenitis-Pistofidis(Co-founder)Keith Flaherty(Co-founder)Brian McKernan(CEO)

Co-investorsThe Engine Ventures

RedShiftBio develops analytical technology that provides real-time measurement of biomolecular structure and concentration, aimed at supporting decisions in biopharmaceutical development and manufacturing.

BiotechDeep TechHardwareBoxborough, US

Thomas O'Lenic(Executive Officer, Director)Eugene Ma(Executive Officer)Charles Marshall(Executive Officer, Director)

BoardFrank Smith(Director)inWilliam Cadogan(Director)Bryson Hollimon(Director)

Co-investorsTechnology Venture Partners

Actym Therapeutics engineers bacteria as a delivery system for therapeutics targeting cancer and fibrotic disease.

BiotechHealthtechBerkeley, US

Christopher D Thanos(Executive Officer, Director, Promoter)Kanad Das(Director)Amit Kumar(Director, Promoter)James Huang(Director)

Adventris is a biotechnology company developing cancer immunotherapy treatments.

BiotechHealthtechBaltimore, US

Jen Herbach(Founder)inWilliam Collis(Founder)inMark Yarchoan(Founder)

Co-investorsY CombinatorRefactor Capital

Alamar Biosciences develops NULISA, an ultra-high-sensitivity, high-specificity technology for analyzing hundreds of protein biomarkers from small biofluid samples, building on the team's prior spatial genomics work (RNAscope).

BiotechDeep TechHealthtechFremont, US

Yuling Luo(Co-founder, CEO and Chair)Steve Chen(Co-founder, COO and Director)Yiyuan Yin(Co-founder, VP of Technology)Tod White(President)Justin McAnear(CFO)inXiao-Jun Ma(CTO)

Co-investorsQiming Venture PartnersSamsara BioCapital

Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches.

BiotechDigital HealthMedical DevicesCambridge, US

DAVID ARTHUR SCOTT(Executive Officer)WINSTON XIA YAN(Executive Officer)FENG ZHANG(Director)ANNIE HAZLEHURST(Director)

BoardKEITH CRANDELL(Director)DAVID R. WALT(Director)in

Co-investorsARCH Venture PartnersOno Venture Investment, Inc.TCG CrossoverThird Rock Ventures

Arima Genomics develops DNA-based cancer diagnostics that combine genomic sequence with 3D genome structural information (via Hi-C sequencing) to detect fusions, rearrangements, ecDNA, and other structural drivers of cancer.

BiotechHealthtechMedical Devices

Sid Selvaraj(Founder & Chief Operating Officer)Tom Willis(Chief Executive Officer)Anthony Schmitt(Senior Vice President, Science)Erin Davis(Vice President, Marketing)

Co-investorsBerkeley Catalyst

Attovia is a biotechnology company focused on drug development and clinical strategy, aiming to bring treatments to patients where none exist and create next-generation therapeutic options.

BiotechDigital Health

Zaneta Odrowaz(Founder)in

Co-investorsEcoR1 CapitalFrazier Life SciencesNextech InvestSanofi VenturesVida VenturesGoldman Sachs

Broken String Biosciences develops tools for genome-wide on- and off-target analysis in gene editing, enabling in-house detection and characterization of gene editing-induced DNA breaks.

AI & Machine LearningBiotechDeep Tech

Co-investorsFirst In VenturesHeran PartnersKorysMérieux Equity Partners

Bullseye Biosciences uses in-cell directed evolution to discover functional therapeutic molecules against challenging intracellular targets such as protein–protein interactions and transcriptional regulation.

BiotechDeep Tech

Corey Gray(Co-founder and CEO)Michael McKeown(Co-founder and Head of Research)

Co-investorsZAKA VC

BiotechPittsburgh, US

Michael Hoerres(Executive Officer, Director)

BoardJames Peters(Director)Steve Grenfell(Director)Paul Schmitt(Director)Noel Doheny(Director)

CubaseBio develops spatial biology tools that enable three-dimensional analysis of biological samples at scale, for drug discovery and biological research.

BiotechDeep TechStockholm, SE

Paulius Mielinis(Founder)Toon Verheyen(Founder)Xiaoyan Qian(Founder)

Co-investorsLeksell Social VenturesNordic Science InvestmentsVoima Ventures

DeepSeq designs biologic drugs using AI trained on massive datasets of real protein interactions, predicting properties such as affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability.

AI & Machine LearningBiotechDeep Tech

Co-investorsZAKA VC

DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBaltimore, US

Victor Velculescu(Executive Officer, Director, Promoter)Peter Bach(Executive Officer)Jennifer Buechel(Executive Officer)Douglas Schenkel(Executive Officer)Nicholas Dracopoli(Executive Officer)

BoardRishi Gupta(Director)in

Co-investorsAV8 VenturesForesite CapitalMenlo VenturesOpen Field CapitalOrbiMedOUP (Osage University Partners)+3 more

Encoded develops gene therapies for neurological disorders through an integrated platform approach.

Biotech

Stephanie Tagliatela(Founder)in

Co-investorsARCH Venture PartnersBioBritGV (Google Ventures)Menlo VenturesSoftBank Vision FundVenrock

Fluent Bio develops software for analyzing single-cell RNA sequencing data, producing count matrices and diagnostic outputs for researchers using Illumina sequencing libraries.

BiotechDeveloper Tools

Co-investorsCivilization Ventures Management, LlcCota CapitalSamsara BioCapital

Fuze Health operates a unified digital healthcare platform spanning digital pharmacy (FuzeRx), clinical services such as diagnostics, screening and genetics (Fuze Services), and data and technology tools (Fuze Technologies).

AI & Machine LearningDigital HealthHealthtechSaaS

Co-investorsHLM Venture PartnersK2 HealthVenturesOlive Tree CapitalSoftBank Vision FundTowerBrook

Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.

BiotechDigital HealthHealthtech

Mark Sylvester(Chief Financial Officer)Andrew Warner(Vice President, Product)Monica Zarb(Vice President, Business Development)Durand Van Arnem(Vice President, Engineering)Alan Rope(Medical Director)

Co-investorsCanaan PartnersDreamers VCEcho Health VenturesGV (Google Ventures)Kaiser Permanente VenturesSamsung Catalyst Fund+3 more

Provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and access to clinical trial opportunities, with a focus on rare conditions.

BiotechDigital HealthHealthtech

Co-investorsiSelect FundCanaan Partners

Hepta develops LiquidTransformer, an AI platform for analyzing cell-free DNA fragments in blood to detect chronic disease molecular signals.

AI & Machine LearningBiotechHealthtechSan Francisco, US

Hamed Amini(Founder)inSoheil Damangir(Founder)

Co-investorsAlumni VenturesAME Cloud VenturesFelicis VenturesSeaX Ventures

Iambic develops AI technologies for drug discovery, using a high-throughput experimental platform to design small-molecule medicines and advance a pipeline of clinical candidates for cancers such as HER2-driven, breast, and ovarian tumors.

AI & Machine LearningBiotechDeep TechSan Diego, US

Tom Miller(Co-Founder & CEO)inFred Manby(Co-Founder & CTO)inThomas Miller(Founder)inNeil Josephson(Chief Medical Officer)inPete Olson(Chief Scientific Officer)inMichael Secora(Chief Financial Officer and Chief Corporate Development Officer)in

Co-investorsAbingworthAscenta CapitalCatalio Capital ManagementAlumni VenturesCatalio Capital Management, LPCoatue Management+4 more

Infinity Bio provides immune system analysis through its proprietary MIPSA antibody reactome profiling platform, which identifies the targets of individual immune responses against human viruses, human proteins (autoimmunity), and allergen proteins.

BiotechDeep TechHealthtechBaltimore, US

Benjamin Larman(Executive Officer, Director)inJoy M Nassif(Executive Officer, Director)Joy Nassif(Executive Officer, Director)

BoardMatthew Hellauer(Director)Herman Scholtz(Director)inCaroline Popper(Director)in

Co-investorsTCP Venture CapitalPTX Capital

Integrated Biosciences is a biotech company developing small molecule therapeutics for age-related diseases, using optogenetics, chemistry, and AI to study aging biology.

AI & Machine LearningBiotechLongevityRedwood City, US

Felix Wong(Executive Officer, Director)inDaniel J. Anderson(Chief Scientific Officer)Themasap Khan(Director)

BoardKeith Loebner(Director)

Co-investorsSutter Hill VenturesCivilization Ventures Management, Llc

Kallyope is a biotechnology company founded by neuroscientists that discovers and develops novel therapeutics targeting neural networks, with a lead candidate in pivotal studies for acute migraine treatment and metabolism programs approaching clinical studies.

BiotechHealthtechNew York City, US

Tom Maniatis(Director)Nancy Thornberry(Executive Officer, Director)Kenneth Clark(Executive Officer)

BoardTerry McGuire(Director)inJoshua Wolfe(Director)inTim Kutzkey(Director)

Co-investorsDns CapitalLux CapitalThe Column GroupPolaris Partners

Kodikaz develops Zip-Code, a non-viral cell-specific delivery platform for gene therapy applications, particularly focused on oncology and cancer treatments.

AI & Machine LearningBiotechMedical DevicesAtlanta, US

Anthony Johnson(Co-Founder & CEO)inDr. Leon Bernal-Mizrachi(Co-Founder, CSO)in

Co-investorsEpidarex CapitalGRA Venture

Lightcast develops a single-cell functional analysis platform that uses droplet-based technology to profile cell function, biomolecule secretion, cell-cell interactions, and targeted cell killing at scale.

BiotechDeep TechHealthtech

Co-investors+ND CapitalLongwall Venture Partners LLPM VenturesOMX VenturesARCH Venture Partners

Lightcast provides a next-generation single-cell functional analysis platform called Envisia that enables massively parallel profiling of cell-cell interactions and biomolecule secretion at scale.

BiotechDeep TechMedical Devices

Co-investorsARCH Venture PartnersPerscitus LLP

NanoCellect develops microfluidic-based cell sorters that operate at low pressure to sort cells with high viability and reduced shear stress, aimed at scientists and researchers.

BiotechHardwareMedical Devices

Chris Neary(CEO)in

Co-investorsVertical Venture PartnersWarburg PincusFusionX Ventures

NuCicer develops improved crop varieties through selective breeding, starting with high-protein chickpeas designed for better nutrition.

AgTechAI & Machine LearningFoodTechDavis, US

Kathryn Cook(Executive Officer, Director)inDouglas Cook(Executive Officer, Director)

BoardPaimun Amini(Director)inJerry Steiner(Director)inCarsten Boers(Director)in

Co-investorsBetter Ventures Central LlcBlue Horizon CorporationLever VCRhapsody Venture PartnersStray Dog Capital

Oncko develops machine learning and experimental platforms to discover optimized multi-drug cancer treatment combinations by screening against resistance mechanisms.

AI & Machine LearningBiotechDeep Tech

Atray Dixit(Co-founder, CEO)inBill Grossman(Co-founder, Strategic Advisor)in

Co-investorsAdverb VenturesTenmile

Developing a diagnostics platform using single-cell analysis and machine learning to rapidly identify bacterial pathogens and determine antibiotic susceptibility.

Co-investorsAMR Action Fund

BiotechAustin, US

Carey-Ann Burnham(Executive Officer, Director)Nicolas Arab(Executive Officer, Director)Johnson Ross(Executive Officer)Bryan Gammon(Director)Oscar Marx(Director)

BoardJunjun Gao(Director)

Co-investorsAMR Action FundIllumina Innovation

Provides insights by analyzing data and content about brands on the internet.

Mcminnville, US

Dale Djerassi(Director)Brian Feucht(Executive Officer)

BoardRoger Lang(Executive Officer, Director)in

Co-investorsInspiration VenturesCerraCap VenturesThe Engine Ventures

Protillion Biosciences develops platform technology for antibody engineering and drug discovery.

AI & Machine LearningBiotechDeep TechCarlsbad, US

Curtis Layton(CEO/Co-Founder)inDavid Walt(Co-Founder)inWill Greenleaf(Co-Founder)inRobert Hollingsworth(Chief Scientific Officer)in

BoardSean Kendall(Director)inMalek Faham(Director)in

Co-investorsARCH Venture Partners

Santa Clara, US

Jekwan Ryu(Executive Officer, Director)Ronald M. Cook(Director)Eric Williams(Executive Officer)Tae Hoon Nahm(Director)

BoardTom Willis(Director, Executive Officer)

BiotechGreenville, US

Kevin Weeks(Executive Officer, Director)Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)John Gustofson(Director)

BoardMike Dial(Director)in

Co-investorsM VenturesMC Healthcare VenturesPappas CapitalSV Health InvestorsDementia Discovery FundHatteras Venture Partners+1 more

Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.

BiotechHealthtechNew York City, US

Adam Yaari(Founder/CEO)inMaxwell Sherman(Founder/CTO)in

Co-investorsMetaplanetY Combinator

HealthtechCambridge, US

Rahul Dhanda(Executive Officer, Director)James Collins(Director)David Walt(Director)in

BoardIssi Rozen(Director)in

Co-investorsCatalio Capital Management, LPGV (Google Ventures)

SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.

BiotechDeep TechHealthtechSouth San Francisco, US

Kenneth Greenberg(Co-Founder, President & CEO)in

Co-investorsVida VenturesLeaps by BayerFoothill VenturesMedical Excellence CapitalVivo CapitalARCH Venture Partners+1 more

Co-investorsKurma Partners

Syntax Bio develops a discovery platform that accelerates stem cell-derived therapies by using its proprietary Cellgorithm technology to control and direct cell differentiation.

BiotechDeep TechMedical Devices

Ryan Clarke(Founder)in

Co-investorsAstellas Venture Management LLCDCVC (Data Collective)DCVC BioDraper AssociatesPortal Innovations

Tagomics is focused on organ health, though the available page content does not provide enough detail about its products, technology, or business model.

BiotechMedical Devices

Co-investorsCalculusCalculus Capital Ltd.IQ CapitalMEIF Proof-of-Concept & Early Stage FundMercia VenturesOMX Ventures+1 more

TissueCypher is a spatial biology and "biologically aware AI" platform from Castle Biosciences that analyzes tissue biopsies to support precision medicine, from drug discovery to clinical diagnostics.

AI & Machine LearningBiotechDigital Health